Australia appears to be gain access to innovative medication for excess weight: Retatrutide. This dual molecule – targeting on both GLP-1 and GIP receptors – demonstrates remarkable results in clinical research, pointing to substantial reductions in BMI. While approval remains with the Therapeuti